PALB2 Chromatin Recruitment Restores Homologous Recombination in BRCA1-deficient Cells Depleted of 53BP1

Overview

Journal Nat Commun

Specialty Biology

Date 2020 Feb 12

PMID 32041954

Citations 36

Authors

Rimma Belotserkovskaya

Elisenda Raga Gil

Nicola Lawrence

Richard Butler

Gillian Clifford

Marcus D Wilson

Stephen P Jackson

Affiliations

Soon will be listed here.

Abstract

Loss of functional BRCA1 protein leads to defects in DNA double-strand break (DSB) repair by homologous recombination (HR) and renders cells hypersensitive to poly (ADP-ribose) polymerase (PARP) inhibitors used to treat BRCA1/2-deficient cancers. However, upon chronic treatment of BRCA1-mutant cells with PARP inhibitors, resistant clones can arise via several mechanisms, including loss of 53BP1 or its downstream co-factors. Defects in the 53BP1 axis partially restore the ability of a BRCA1-deficient cell to form RAD51 filaments at resected DSBs in a PALB2- and BRCA2-dependent manner, and thereby repair DSBs by HR. Here we show that depleting 53BP1 in BRCA1-null cells restores PALB2 accrual at resected DSBs. Moreover, we demonstrate that PALB2 DSB recruitment in BRCA1/53BP1-deficient cells is mediated by an interaction between PALB2's chromatin associated motif (ChAM) and the nucleosome acidic patch region, which in 53BP1-expressing cells is bound by 53BP1's ubiquitin-directed recruitment (UDR) domain.

Citing Articles

The Landscape of PARP Inhibitors in Solid Cancers.

Muzzana M, Broggini M, Damia G Onco Targets Ther. 2025; 18:297-317.

PMID: 40051775 PMC: 11884256. DOI: 10.2147/OTT.S499226.

Hodgkin lymphoma and Ewing sarcoma in pediatric patient carrying germline variant: a case report and literature review.

Czarny J, Galli D, Wziatek A, Pastorczak A, Szmyd B, Przybyszewski B Front Oncol. 2025; 15:1514697.

PMID: 40040726 PMC: 11876119. DOI: 10.3389/fonc.2025.1514697.

The N-terminal region of DNMT3A engages the nucleosome surface to aid chromatin recruitment.

Wapenaar H, Clifford G, Rolls W, Pasquier M, Burdett H, Zhang Y EMBO Rep. 2024; 25(12):5743-5779.

PMID: 39528729 PMC: 11624362. DOI: 10.1038/s44319-024-00306-3.

Distinct mobility patterns of BRCA2 molecules at DNA damage sites.

Paul M, Aaron J, Wait E, Van Genderen R, Tyagi A, Kabbech H Nucleic Acids Res. 2024; 52(14):8332-8343.

PMID: 38953170 PMC: 11317164. DOI: 10.1093/nar/gkae559.

A RAD18-UBC13-PALB2-RNF168 axis mediates replication fork recovery in BRCA1-deficient cancer cells.

Cybulla E, Wallace S, Meroni A, Jackson J, Agashe S, Tennakoon M Nucleic Acids Res. 2024; 52(15):8861-8879.

PMID: 38943334 PMC: 11347138. DOI: 10.1093/nar/gkae563.

References

Nimonkar A, Genschel J, Kinoshita E, Polaczek P, Campbell J, Wyman C . BLM-DNA2-RPA-MRN and EXO1-BLM-RPA-MRN constitute two DNA end resection machineries for human DNA break repair. Genes Dev. 2011; 25(4):350-62. PMC: 3042158. DOI: 10.1101/gad.2003811. View

Jensen R, Carreira A, Kowalczykowski S . Purified human BRCA2 stimulates RAD51-mediated recombination. Nature. 2010; 467(7316):678-83. PMC: 2952063. DOI: 10.1038/nature09399. View

Liu J, Doty T, Gibson B, Heyer W . Human BRCA2 protein promotes RAD51 filament formation on RPA-covered single-stranded DNA. Nat Struct Mol Biol. 2010; 17(10):1260-2. PMC: 2952495. DOI: 10.1038/nsmb.1904. View

Cruz-Garcia A, Lopez-Saavedra A, Huertas P . BRCA1 accelerates CtIP-mediated DNA-end resection. Cell Rep. 2014; 9(2):451-9. DOI: 10.1016/j.celrep.2014.08.076. View

Zhang F, Fan Q, Ren K, Andreassen P . PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2. Mol Cancer Res. 2009; 7(7):1110-8. PMC: 4928587. DOI: 10.1158/1541-7786.MCR-09-0123. View

Zhang F, Ma J, Wu J, Ye L, Cai H, Xia B . PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr Biol. 2009; 19(6):524-9. PMC: 2750839. DOI: 10.1016/j.cub.2009.02.018. View

Bunting S, Callen E, Wong N, Chen H, Polato F, Gunn A . 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell. 2010; 141(2):243-54. PMC: 2857570. DOI: 10.1016/j.cell.2010.03.012. View

Bouwman P, Aly A, Escandell J, Pieterse M, Bartkova J, van der Gulden H . 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat Struct Mol Biol. 2010; 17(6):688-95. PMC: 2912507. DOI: 10.1038/nsmb.1831. View

Certo M, Ryu B, Annis J, Garibov M, Jarjour J, Rawlings D . Tracking genome engineering outcome at individual DNA breakpoints. Nat Methods. 2011; 8(8):671-6. PMC: 3415300. DOI: 10.1038/nmeth.1648. View

10.

Agirre J, Iglesias-Fernandez J, Rovira C, Davies G, Wilson K, Cowtan K . Privateer: software for the conformational validation of carbohydrate structures. Nat Struct Mol Biol. 2015; 22(11):833-4. DOI: 10.1038/nsmb.3115. View

11.

Bowman-Colin C, Xia B, Bunting S, Klijn C, Drost R, Bouwman P . Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer. Proc Natl Acad Sci U S A. 2013; 110(21):8632-7. PMC: 3666744. DOI: 10.1073/pnas.1305362110. View

12.

Chen J, Silver D, Cantor S, Livingston D, Scully R . BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway. Cancer Res. 1999; 59(7 Suppl):1752s-1756s. View

13.

Reczek C, Szabolcs M, Stark J, Ludwig T, Baer R . The interaction between CtIP and BRCA1 is not essential for resection-mediated DNA repair or tumor suppression. J Cell Biol. 2013; 201(5):693-707. PMC: 3664708. DOI: 10.1083/jcb.201302145. View

14.

Polato F, Callen E, Wong N, Faryabi R, Bunting S, Chen H . CtIP-mediated resection is essential for viability and can operate independently of BRCA1. J Exp Med. 2014; 211(6):1027-36. PMC: 4042650. DOI: 10.1084/jem.20131939. View

15.

Zhou Y, Caron P, Legube G, Paull T . Quantitation of DNA double-strand break resection intermediates in human cells. Nucleic Acids Res. 2013; 42(3):e19. PMC: 3919611. DOI: 10.1093/nar/gkt1309. View

16.

Densham R, Garvin A, Stone H, Strachan J, Baldock R, Daza-Martin M . Human BRCA1-BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection. Nat Struct Mol Biol. 2016; 23(7):647-55. PMC: 6522385. DOI: 10.1038/nsmb.3236. View

17.

Yazinski S, Comaills V, Buisson R, Genois M, Nguyen H, Ho C . ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells. Genes Dev. 2017; 31(3):318-332. PMC: 5358727. DOI: 10.1101/gad.290957.116. View

18.

Zhao W, Steinfeld J, Liang F, Chen X, Maranon D, Ma C . BRCA1-BARD1 promotes RAD51-mediated homologous DNA pairing. Nature. 2017; 550(7676):360-365. PMC: 5800781. DOI: 10.1038/nature24060. View

19.

Nacson J, Krais J, Bernhardy A, Clausen E, Feng W, Wang Y . BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance. Cell Rep. 2018; 24(13):3513-3527.e7. PMC: 6219632. DOI: 10.1016/j.celrep.2018.08.086. View

20.

Schermelleh L, Carlton P, Haase S, Shao L, Winoto L, Kner P . Subdiffraction multicolor imaging of the nuclear periphery with 3D structured illumination microscopy. Science. 2008; 320(5881):1332-6. PMC: 2916659. DOI: 10.1126/science.1156947. View